UPI: Promising pancreatic cancer treatment
Media highlights potential new cancer therapy that could be in clinical trials soon
A new multi-drug combination therapy for pancreatic cancer is inching toward clinical trials in humans, according to University of Cincinnati researchers.
The drug compound, called SapC-DOPS, combines chemotherapy with targeted therapy and is capable of killing the cells that cause a number of cancers, including pancreatic cancer, which is notoriously difficult to treat.
"Based on pre-clinical studies, it has the potential to improve pancreatic cancer treatment," Xiaoyang Qi, PhD, a professor of hematology oncology at the University of Cincinnati College of Medicine and member of the UC Cancer Center. Qi is a lead author on the study which was published in the academic journal Molecular Therapy.
The Cincinnati Enquirer also covered this research.
Featured photo of pancreatic cancer cells courtesy of National Institutes of Health. Credit/Min Yu/Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Engineers develop stress test to measure cortisol
May 12, 2025
Yahoo! Finance highlights research into home tests that can diagnose stress and cardiac issues.
Ladies of Anavlochos: Tech sheds light on ancient Greek figurines
May 12, 2025
The Greek Reporter and other news outlets highlighted work by the University of Cincinnati's Department of Classics using experimental archaeology to explore rites behind Bronze Age figurines discovered at Anavlochos, Crete.
The latest efforts in cervical cancer prevention
May 12, 2025
Medical Laboratory Observer interviewed the University of Cincinnati Cancer Center's Leeya Pinder to discuss the current state and future of cervical cancer prevention.